-
ASCO GI 2025: What I Look Forward to in Pancreatic Cancer - 5 hour(s) ago
Dear Colleagues, I am looking forward to several important clinical trials on pancreatic cancer at ASCO GI. Updates by Dr. Vincent Picozzi on Pamrevlumab in…
-
New Therapeutic Targets in MDS: Updates From ASH 2024 - 18 hour(s) ago
Dear readers, I hope the end of 2024 left you in high spirits. As we start a new year, I want to capitalize on that…
-
Reverse Plaque With Intensive Cholesterol Control - 4 day(s) ago
Dear readers, It is a rare goal in a cardiology practice to discuss plaque reversal with a patient, although data dating back to at least…
-
Dear readers, As we welcome 2025, let us reflect on some of last year’s biggest accomplishments and consider where the genitourinary oncology field may be…
-
New Year, New Data: 2025 Brings Key Updates in Lung Cancer - 9 day(s) ago
Dear readers, It’s been a notable start to 2025 when it comes to lung cancer treatment and research. In the first week of the year,…